Your account is not claimed yet. You can sign up with ORCID to claim your account.

Peter W Janes

Years Active: 2016-2023
Publications (10 Years): 6

Monash University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Monash University

Australia

Adjunct Senior Research Fellow :: Monash Biomedicine Discovery Institute and Dept of Biochemistry and Molecular Biology

Publications

Sakshi Arora, Andrew M Scott, Peter W Janes
Eph Receptors in Cancer. Biomedicines 11 (2) (2023)
Sakshi Arora, Andrew M Scott, Peter W Janes
Eph Receptors in Cancer. Biomedicines 11 (2) (2023)
Sakshi Arora, Andrew M Scott, Peter W Janes
Eph Receptors in Cancer. Biomedicines 11 (2) (2023)
Mary E Vail, Rae H Farnsworth, Linda Hii, Stacey Allen, Sakshi Arora, Robin L Anderson, Ross A Dickins, Akira Orimo, Sunny Z Wu, Alexander Swarbrick, Andrew M Scott, Peter W Janes
Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression. Cancers 15 (18) (2023)
Hengkang Yan, Mary E Vail, Linda Hii, Nancy Guo, Paul J McMurrick, Karen Oliva, Simon Wilkins, Nayanendu Saha, Dimitar B Nikolov, Fook-Thean Lee, Andrew M Scott, Peter W Janes
Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours. Cancers 14 (13) (2022)
Lakmali Atapattu, Nayanendu Saha, Chanly Chheang, Moritz F Eissman, Kai Xu, Mary E Vail, Linda Hii, Carmen Llerena, Zhanqi Liu, Katja Horvay, Helen E Abud, Ulrike Kusebauch, Robert L Moritz, Bi-Sen Ding, Zhongwei Cao, Shahin Rafii, Matthias Ernst, Andrew M Scott, Dimitar B Nikolov, Martin Lackmann, Peter W Janes
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth. The Journal of experimental medicine 213 (9) (2016)

Peter W Janes.css-eqlu8i{font-size:small;padding-left:4px;}